Astrana Health Inc (ASTH): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Astrana Corp (ASTH)

The Astrana Health, Inc. (ASTH) integrated medical assistant platform is effectively scaling its clinic network by optimizing administrative costs. Growth is supported by an AI-driven preventive diagnostics system that reduces therapy expenses. The smoothed P/S ratio for Astrana Health, Inc. (ASTH), based on GURU.Markets data shown on this chart, currently stands at 0.40. The strategy concludes with the implementation of ESG standards through the digitalization of documentation and infrastructure energy efficiency.

Price-to-Revenue Ratio: Astrana Health Inc (ASTH) for 07/04/2022 - 11/13/2026

Apollo Medical Holdings (ASTH) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price astranahealth.com|ASTH - Price Target Chart
- stock exchange capitalization data:
Market Value Apollo Medical Holdings|ASTH - Enterprise Value
- book capitalization indicators:
Book Value per Share Astrana Health|ASTH - Company Book Value|Capitalization to Book Value Ratio astranahealth.com|ASTH - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Astrana Health, Inc.|ASTH - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Astrana Corp|ASTH - Company Aggregate Debts|Debt to Net Assets Ratio Apollo Medical Holdings|ASTH - Company Long-Term Debts|Short-Term Debt Astrana Health|Quick Ratio astranahealth.com
- company profitability and valuation multiples indicators:
ASTH - Company Net Income|Expected Profit Astrana Health, Inc.|ASTH - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Astrana Health Inc|ASTH - PEG Multiple|Business Value to Operating Income Before Depreciation Apollo Medical Holdings|ASTH - Operating profit before deduction of amortization|Earnings per share for the trailing year Astrana Health|ASTH - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months astranahealth.com|ASTH - Earnings per share growth in current year|Projected earnings per share growth rate for next year Astrana Health, Inc.
- total revenue and sales volume data:
ASTH - Revenue and Sales Volume|Company Future Sales Volume astranahealth.com|ASTH - Market Cap to Revenue|Market Cap to Expected Sales Ratio Apollo Medical Holdings
General company analysis:astranahealth.com, ASTH
Signature product of Astrana Corp

For Astrana Health, Inc. (ASTH), which is scaling its IT platform through clinic acquisitions, the P/S multiple serves as an indicator of market confidence in the pace of business expansion. The price-to-sales ratio trend reflects the relationship between market capitalization and annual sales volume, allowing investors to perform a real-time assessment of the premium paid for future revenue growth and compare asset value with the actual scale of operational activity.

Competing companies

Market Cap to Sales Volume HCA|Price-to-Revenue Ratio Tenet Healthcare Corporation THC|Market Capitalization-to-Revenue Ratio FMS|Solventum Inc. - P/S Multiple|EHC - P/S Multiple|uhsinc.com (UHS) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio DVA|RDNT (RadNet) - P/S Multiple|P/S Multiple Option Care|Market Cap to Revenue SGRY (Surgery Partners Corp)|PINC (Premier Health) - Market Capitalization-to-Revenue Ratio|P/S Multiple EYE (National Vision Holdings)|Market Capitalization-to-Revenue Ratio PGNY|Ardent Health Partners - P/S Multiple|Price to Sales Select Medical Corporation|MD: P/S Multiple|U.S. Physical Therapy, Inc. (USPH) - P/S Multiple|Price-to-Revenue Ratio The Pennant Group, Inc.|Price-to-Revenue Ratio ORGO|Market Cap to Revenue NUTX (Nutex Health)|Market Cap to Sales Volume AUNA|P/S Multiple SBC (SBC Medical Group Holdings Inc.)|Market Capitalization-to-Revenue Ratio EOLS|CYH: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio SKIN (The Beauty Health)|MDWD: P/S Multiple|BTMD - Price-to-Revenue Coefficient|Price-to-Revenue Ratio The Joint Corporation|Market Cap to Revenue Ratio DCGO (DocGo, Inc)|P/S Multiple PIII|Market Cap to Revenue gaintherapeutics.com GANX|EUDA Health Holdings Limited - Market Cap to Revenue|Price-to-Revenue Coefficient Basel Medical (BMGL)|CollPlant Ltd - P/S Multiple|CUPR - P/S Multiple|Concord Medical Services (CCM) - Price-to-Revenue Ratio|AMS - Price-to-Revenue Coefficient|Market Cap to Revenue MRM|ALBT (Avalon GloboCare Corporation) - Market Cap to Sales Volume|P/S Multiple DHAI|XAGE (Carmell Corp) - Market Capitalization-to-Revenue Ratio|NewGenIvf Group Limited - Market Cap to Revenue|Market Cap to Sales Volume ATIP (ATI Physical Therapy Inc.)|CMAX - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio KDLY (Kindly MD Inc)|MODV: P/S Multiple|Price to Sales Novo Integrated Sciences Corp (NVOS)|SSY (SunLink Health Systems Inc.) - P/S Multiple|P/S Multiple imacholdings.comm